Difference between revisions of "Part:BBa K1604030"
(→Usage and Biology) |
Cridelbianco (Talk | contribs) (→Usage and Biology) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 9: | Line 9: | ||
<div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/e/ed/Unitn_pics_2015_NADpathway.png" style="width:75%;"></img></div></html> | <div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/e/ed/Unitn_pics_2015_NADpathway.png" style="width:75%;"></img></div></html> | ||
<p style="width:600px; margin-left:150px; margin-bottom:60px; | <p style="width:600px; margin-left:150px; margin-bottom:60px; | ||
− | text-align:justify "><b>FIGURE 1. Biochemical pathway of NAD synthesis.</b> PncB gene encodes the transcription of the NARPTase which catalyzes the formation of nicotinate mono-nucleotide from nicotinic acid. This is considered the limiting step of the synthesis of NAD+. </p> | + | text-align:justify "><b>FIGURE 1. Biochemical pathway of NAD<sup>+</sup> synthesis.</b> PncB gene encodes the transcription of the NARPTase which catalyzes the formation of nicotinate mono-nucleotide from nicotinic acid. This is considered the limiting step of the synthesis of NAD+. </p> |
<div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/b/b3/Unitn_pics_2015_WellRatioNAD-NADH.png" style="width:80%;"></img></div></html> | <div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/b/b3/Unitn_pics_2015_WellRatioNAD-NADH.png" style="width:80%;"></img></div></html> | ||
Line 18: | Line 18: | ||
<div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/6/63/Unitn_pics_2015_NADAnaerobic.png" style="width:50%;"></img></div></html> | <div style="text-align:center"><html><img src="https://static.igem.org/mediawiki/parts/6/63/Unitn_pics_2015_NADAnaerobic.png" style="width:50%;"></img></div></html> | ||
<p style="width:600px; margin-left:150px; margin-bottom:60px; | <p style="width:600px; margin-left:150px; margin-bottom:60px; | ||
− | text-align:justify "><b>FIGURE 3. PncB enhances NAD production by 13 fold in anaerobic condition in LB broth.</b> NAD/NADH ratio between negative control and cell expressing BBa_K1604031, both samples were growth in LB medium. Both samples after 6 hours of induction in Thermoshaker (37°C, 190 rpm) were transferred in sealed glass bottles with a rubber septum under anaerobic work station to keep samples without oxygen. PncB does increase NAD+ levels by ~ 13 fold. In this graphic there are no bars of standard deviation because test was made for an only biological sample for negative control araC-pBAD and two samples for pncB because we have limiting glass to put under anaerobic work station. </p> | + | text-align:justify "><b>FIGURE 3. PncB enhances NAD production by 13 fold in anaerobic condition in LB broth.</b> NAD/NADH ratio between negative control and cell expressing BBa_K1604031, both samples were growth in LB medium. Both samples after 6 hours of induction in Thermoshaker (37°C, 190 rpm) were transferred in sealed glass bottles with a rubber septum under anaerobic work station to keep samples without oxygen. The cells were grown for additional 20 hours. NAD<sup+</sup> and NADH levels were quantified with a colorimetric assay as described in Figure 2. PncB does increase NAD+ levels by ~ 13 fold. In this graphic there are no bars of standard deviation because test was made for an only biological sample for negative control araC-pBAD and two samples for pncB because we have limiting glass to put under anaerobic work station. </p> |
Latest revision as of 22:40, 17 September 2015
pncB
pncB encodes for the enzyme NAPRTase (nicotinic acid phosphoribosyl-transferase). It catalyzes the formation of nicotinate mono-nucleotide, a direct precursor of NAD, from NA.[1] [2] [3].
Usage and Biology
FIGURE 1. Biochemical pathway of NAD+ synthesis. PncB gene encodes the transcription of the NARPTase which catalyzes the formation of nicotinate mono-nucleotide from nicotinic acid. This is considered the limiting step of the synthesis of NAD+.
FIGURE 2. PncB increases NAD+ levels by 2.5 fold and NADH levels by 1.4 fold when expressed in NEB10β. NAD+ and NADH levels were calculated with a colorimetric assay using the Sigma NAD/NADH quantification kit (MAK037) following the instructions described in the technical bulletin. The kit provides the measures of NAD+ levels indirectly from total levels of NAD + NADH and NADH only. Panel A. Colorimetric assay for NAD/NADH quantification. Panel B. NAD/NADH levels for three biological samples expressing BBa_K1604031 and one negative control expressing BBa_K731201.
FIGURE 3. PncB enhances NAD production by 13 fold in anaerobic condition in LB broth. NAD/NADH ratio between negative control and cell expressing BBa_K1604031, both samples were growth in LB medium. Both samples after 6 hours of induction in Thermoshaker (37°C, 190 rpm) were transferred in sealed glass bottles with a rubber septum under anaerobic work station to keep samples without oxygen. The cells were grown for additional 20 hours. NAD<sup+</sup> and NADH levels were quantified with a colorimetric assay as described in Figure 2. PncB does increase NAD+ levels by ~ 13 fold. In this graphic there are no bars of standard deviation because test was made for an only biological sample for negative control araC-pBAD and two samples for pncB because we have limiting glass to put under anaerobic work station.
For more information about the pncB (BBa_K1604030) characterization go on BBa_K1604031 page, or on Unitn iGEM 2015 project checking out our Wiki: Unitn iGEM wiki 2015.
-
Susana J. Berrıos-Rivera, K.-Y. San, and G. N. Bennett. (2002) Metabolic Engineering 4, 238–247
-
Marcel G. Wubbolts, Peter Terpstra, Jan B. van Beilen, Jaap Kingma, H. A. Rene Meesters, and Bernard Witholt. (1990) JBC, 265 (29), 17665-72
-
Ka-Yiu San, George N. Bennett, Susana J. Berríos-Rivera, Ravi V. Vadali, Yea-Tyng Yang, Emily Horton, Fred B. Rudolph, Berna Sariyar, and Kimathi Blackwood (2002) Metabolic Engineering, 4, 182–192
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 1106
- 1000COMPATIBLE WITH RFC[1000]